Abstract: Systems and methods for delivering a therapeutic agent to target tissue using a plurality of drug delivery platforms each having the therapeutic drug embedded as part of the drug delivery platform. Each drug delivery platform is implanted into a target tissue, and the active agent elutes out of the drug delivery platform for a target period of time, delivering a therapeutic dose of the drug for that period of time. The duration of therapy for an implant can be from 3 to 12 months, longer, or shorter.

Abstract: A nasal stent includes an elongated tubular body having proximal and distal ends extending along a longitudinal axis. The elongated body includes a repeating pattern of W-shaped members extending around the tubular body separated by longitudinally-oriented and offset struts. The elongated tubular body is selectively transitionable between an expanded configuration and a crimped configuration, wherein the pattern of W-shaped members and struts interleave allowing the elongated tubular body to maintain substantially the same length when disposed in the expanded configuration and the crimped configuration.

Abstract: Systems and methods for delivering a therapeutic agent to target tissue using a plurality of drug delivery platforms each having a polymer scaffold and the therapeutic agent contained within the polymer scaffold. Each drug delivery platform of the plurality of drug delivery platforms is implanted into the target tissue, allowing the therapeutic agent to elute from each drug delivery platform of the plurality of drug delivery platforms for a target period of time, delivering a therapeutic dose of the therapeutic agent for the target period of time. Each drug delivery platform of the plurality of drug delivery platforms is allowed to biodegrade within the target tissue.